Active Ingredient History
Cerebrolysin is a mixture of enzymatically treated peptides derived from pig brain whose constituents can include brain-derived neurotrophic factor (BDNF), glial cell line-derived neurotrophic factor (GDNF), nerve growth factor (NGF), and ciliary neurotrophic factor (CNTF). Wikipedia
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Alzheimer Disease (Phase 2)
Bell Palsy (Phase 1/Phase 2)
Brain Injuries, Traumatic (Phase 4)
Brain Ischemia (Phase 2/Phase 3)
CADASIL (Phase 2)
Cerebral Palsy (Phase 1)
Child Development (Phase 1)
Consciousness Disorders (Phase 4)
COVID-19 (Phase 4)
Deficiency Diseases (Phase 2/Phase 3)
Down Syndrome (Phase 2)
Drugs, Investigational (Phase 4)
Hemorrhagic Stroke (Phase 4)
Hypoxia-Ischemia, Brain (Phase 2)
Infant, Premature (Phase 1)
Intracranial Aneurysm (Phase 2/Phase 3)
Ischemic Stroke (Phase 4)
Stroke (Phase 4)
Subarachnoid Hemorrhage (Phase 2/Phase 3)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue